252 related articles for article (PubMed ID: 17460946)
1. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite.
Inal A; Altintas DU; Yilmaz M; Karakoc GB; Kendirli SG; Sertdemir Y
J Investig Allergol Clin Immunol; 2007; 17(2):85-91. PubMed ID: 17460946
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy.
Harmanci K; Razi CH; Toyran M; Kanmaz G; Cengizlier MR
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):7-13. PubMed ID: 20527510
[TBL] [Abstract][Full Text] [Related]
3. Development of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy.
Gulen F; Zeyrek D; Can D; Altinoz S; Koksoy H; Demir E; Tanac R
Asian Pac J Allergy Immunol; 2007 Mar; 25(1):7-11. PubMed ID: 17891916
[TBL] [Abstract][Full Text] [Related]
4. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study.
Pajno GB; Barberio G; De Luca F; Morabito L; Parmiani S
Clin Exp Allergy; 2001 Sep; 31(9):1392-7. PubMed ID: 11591189
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of house dust mite sublingual immunotherapy in monosensitized and polysensitized children with respiratory allergic diseases.
Li P; Li Q; Huang Z; Chen W; Lu Y; Tian M
Int Forum Allergy Rhinol; 2014 Oct; 4(10):796-801. PubMed ID: 25145986
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of specific immunotherapy on house dust mite-induced allergic rhinitis in China.
Peng H; Li CW; Lin ZB; Li TY
Otolaryngol Head Neck Surg; 2013 Jul; 149(1):40-6. PubMed ID: 23569202
[TBL] [Abstract][Full Text] [Related]
7. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
Marogna M; Spadolini I; Massolo A
Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
[TBL] [Abstract][Full Text] [Related]
8. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
9. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
10. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
[TBL] [Abstract][Full Text] [Related]
11. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
12. Specific IgG4 production during house dust mite immunotherapy among age, gender and allergic disease populations.
Lai X; Li J; Xiao X; Liu E; Zhang C; Wang H; Gjesing B; Zhong N; Spangfort MD
Int Arch Allergy Immunol; 2013; 160(1):37-46. PubMed ID: 22948109
[TBL] [Abstract][Full Text] [Related]
13. Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy.
Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
Asian Pac J Allergy Immunol; 2013 Sep; 31(3):233-41. PubMed ID: 24053706
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic children.
Silvestri M; Rossi GA; Cozzani S; Pulvirenti G; Fasce L
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):335-40. PubMed ID: 10541426
[TBL] [Abstract][Full Text] [Related]
15. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.
Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE
Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400
[TBL] [Abstract][Full Text] [Related]
16. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
[TBL] [Abstract][Full Text] [Related]
17. A study of home characteristics in children with allergic rhinitis and asthma.
Salehi M; Moradi S; Chavoshzadeh Z; Gorji FA; Khoramrooz Z; Rezaei N
Acta Clin Croat; 2011 Jun; 50(2):225-7. PubMed ID: 22263386
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the efficacy and safety of standardized dust mite allergen specific immunotherapy to children with allergic asthma].
Song W; Lin X; Xie H; Chai R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1193-6. PubMed ID: 24617000
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
20. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
